EW: Rasio kapitalisasi marang pendapatan Edwards
Edwards Lifesciences dominates the cardiology sector thanks to its unique minimally invasive valve replacement methods. The price-to-sales ratio visualizes this premium valuation, where the 9.10 level reflects the current magnitude of market expectations. Patents and an evidence-based foundation protect the issuer's position from competitive pressure, while a strategy of acquiring small startups ensures organic growth through the integration of new developments.
Rincian metrik lan analitis perusahaan Edwards Lifesciences Corp (EW)
- kuotasi saiki lan rata-rata prakiraan nilai:
- informasi kapitalisasi pasar:
- rincian valuasi buku bisnis:
- statistik kawajiban utang lan likuiditas:
Total Utang marang Modal Edwards Lifesciences|EW - Utang jangka dawa marang ekuitas|Utang jangka cendhak marang ekuitas Edwards Lifesciences Inc.|EW - Gunggung utang perusahaan|Rasio utang marang aset resik Edwards Lifesciences Corp|EW - Utang jangka dawa perusahaan|Utang jangka cendhak Edwards Lifesciences|Likuiditas kritis edwards.com
- data bathi resik lan rasio valuasi:
EW - Penghasilan resik|Proyeksi bathi mangsa ngarep Edwards Lifesciences|EW - Pangali P/E|Kapitalisasi marang proyeksi bathi Edwards|EW - Rasio rega marang bathi tumrap wutah|Rasio nilai perusahaan marang bathi operasional sadurunge panyusutan Edwards Lifesciences Corp|EW - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Bathi resik saben saham sajrone 12 wulan pungkasan Edwards Lifesciences|EW - Bathi resik saben saham (EPS TTM)|Wutah bathi saben saham ing petungan tahunan sajrone rolas wulan pungkasan edwards.com|EW - Wutah bathi saben saham ing taun lumaku|Proyeksi kacepetan wutah bathi saben saham kanggo taun ngarep Edwards Lifesciences
- rincian pendapatan lan dodolan emiten:
Ringkesan analitik perusahaan:edwards.com, EW
The P/S ratio determines the market value of one dollar of sales, allowing for an assessment of the premium paid for an asset relative to its revenue. By analyzing the divergence of the P/S from its historical average at the current value of 9.10, an investor compares the multiple with the business uniqueness of Edwards Lifesciences (EW), whose dominance in the minimally invasive valve segment justifies a premium valuation due to a lack of technological alternatives.
Perusahaan pesaing
BSX - Rega marang dodolan|Multiplikator P/S RMD (ResMed)|PODD: Rasio kapitalisasi marang pendapatan|Zimmer - Multiplikator P/S|Koefisien rega marang pendapatan CooperSurgical COO|ALGN: Multiplikator P/S|Kapitalisasi marang pendapatan globusmedical.com|TMDX (TransMedics Group, Inc.) - Multiplikator P/S|Multiplikator P/S Alphatec Holdings|Rasio rega marang pendapatan Artivion Inc (AORT)|Rasio rega marang pendapatan ENOV (Enovis Inc.)|Integra LifeSciences - Kapitalisasi marang pendapatan|Rasio kapitalisasi pasar marang pendapatan ESTA|Beta Bionics - Multiplikator P/S|Rega marang dodolan IRADIMED Corp|Embecta Inc. (EMBC) - Rasio rega marang pendapatan|Multiplikator rega marang pendapatan Tandem Corp TNDM|Kapitalisasi marang pendapatan AXGN|Multiplikator P/S si-bone.com|Multiplikator P/S OFIX|Koefisien rega marang pendapatan Bioventus Inc|Rasio rega marang pendapatan OrthoPediatrics KIDS|TMCI (Treace Corp) - Rasio rega marang dodolan|SRTA - Rasio rega marang pendapatan|carlsmed.com (CARL) - Kapitalisasi marang pendapatan|RXST: Multiplikator P/S|Rega marang dodolan ClearPoint Neuro (CLPT)|Rasio rega marang pendapatan Stereotaxis Corp|Rasio kapitalisasi marang pendapatan STIM (Neuronetics, Inc)|Kapitalisasi marang pendapatan SGHT (Sight Sciences, Inc.)|Kapitalisasi marang volume dodolan OBIO|Multiplikator P/S ANIK (Anika Therapeutics, Inc.)|InspireMD Inc (NSPR) - Rega marang dodolan|Jin Medical International Ltd - Multiplikator P/S|VANI (Vivani Medical, Inc.) - Rasio kapitalisasi marang pendapatan|XTNT (xtantmedical.com) - Kapitalisasi marang pendapatan|Kapitalisasi marang pendapatan n1mtc.com|MODD (Modular Medical Inc) - Multiplikator P/S|Multiplikator P/S Myomo Inc.|Rasio rega marang pendapatan Envoy Medical, Inc (COCH)|VVOS (Vivos Therapeutics Inc) - Rasio kapitalisasi pasar marang pendapatan|Multiplikator P/S NVNO (enVVeno Medical)|SINT: Rasio kapitalisasi marang pendapatan|TNON - Rasio rega marang pendapatan|Koefisien rega marang pendapatan ReWalk Robotics LFWD|AMIX (autonomix.com) - Kapitalisasi marang pendapatan|INVO Fertility Corp - Rasio kapitalisasi pasar marang pendapatan|Rasio rega marang pendapatan Bone Biologics|Rasio rega marang pendapatan AXNX|Multiplikator P/S BIOL|Koefisien rega marang pendapatan dynatronics.com|Multiplikator P/S FNA (Paragon 28)|INVO (INVO Bioscience Inc.) - Rasio rega marang dodolan
